0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch global psoriatic arthritis treatment market size status forecast 2025.Your search for "" gave back 1533058 results.
Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of $19.06 billion over 2022-2031...
Catalog:
Grace Market Data
January 2022
Price: USD 2,600.00
Europe autoimmune disease diagnostics market was valued at $1,312.0 million in 2021 and will grow by 8.3% annually over 2021-2031 owing to the...
Catalog:
Grace Market Data
January 2022
Price: USD 2,600.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Global autoimmune disease diagnostics market will reach $10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing...
Catalog:
Grace Market Data
January 2022
Price: USD 3,100.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
LPI
March 2023
Price: USD 3,660.00
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA...
Catalog:
Global Markets Direct
July 2022
Price: USD 3,500.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
LPI
February 2023
Price: USD 3,660.00
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The “Arthritic Therapeutic Industry Forecast” looks at past sales and reviews total world Arthritic Therapeutic sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
